Skip to content

Comparison between effect of bala tail and tila tail nasya,pichu,pana in nasal obstruction(nasanaha)

Comparative Clinical Evaluation of Bala Tail and Tila Tail Nasya,Pichu and Pana in Nasanaha

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/042996
Enrollment
40
Registered
2022-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: J069- Acute upper respiratory infection,unspecified

Interventions

None listed

Sponsors

Patanjali ayurvedic hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients suffering with clinical features of nasanaha (nasal obstruction) 2. Age group between 15 to 60 years 3.Patient having atleast 1-2 associated complaints e.g- headache, nasal discharge ,discomfort in nose, congested nasal mucosa and turbinates and reduced perception of smell 4. Patients yogya for nasya and pichu karma

Exclusion criteria

Exclusion criteria: 1. Age group below 15 & above 60 years 2 .patients with any other specific reason of nasal obstruction e.g nasal polyp, adenoids hypertrophy, tumours, carcinoma, foreign body, trauma ,any sinonasal surgeries, epistaxis etc. 3 .patients suffering with acute rhinitis or sinusitis. 4. patients suffering with COPD,or any other severe systemic 5.pregnant women and lactating mother

Design outcomes

Primary

MeasureTime frame
Subjective Parameter-Grading will be done considering signs & symptoms of nasanaha.. Timepoint: For subjective parameter 1st and 30th day

Secondary

MeasureTime frame
Objective parameter..x ray pns, anterior rhinoscopyTimepoint: For objective parameter on 1 and 30 thday of trial

Countries

India

Contacts

Public ContactDr preeti pahwa

Patanjali bhartiya ayurvigyan evum anusandhan sansthan

drpreeti25@gmail.com9953117417

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026